Amgen INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ

14 Feb 2025

AMGN

10-K: Amgen's 2024 10-K Filing: Focus on Pipeline, Manufacturing, and Regulatory Landscape

Amgen's 2024 10-K filing highlights pipeline advancements, manufacturing expansions, and navigation of a complex regulatory environment, including the impact of the Inflation Reduction Act.

NASDAQ

14 Feb 2024

AMGN

Amgen INC

10-K: Amgen Details Securities Registration and Debt Obligations in 10-K Filing

Amgen's 10-K filing outlines the company's registered securities, including common stock and senior notes, and details their associated rights and obligations.